• The PhD program is part of the EU-funded Marie Skłodowska-Curie Doctoral Network (DN): GetRadi – “Gene Therapy of Rare Diseases”
• This research will include the testing of CRISPR-Cas9 variants (i.e., nickases and prime editors) focusing on viral vectors as delivery agents
• The fellowship should lead to a PhD thesis and is for a minimum duration of three years funded by the Horizon Europe programme
• Your research is expected to identify an integrated genome-editing toolbox capable of safer and efficient gene correction in human cells

Deadline for applications: 20 October, 2022